Literature DB >> 19758374

The role of T helper type 17 cells in inflammatory arthritis.

S Sarkar1, L A Cooney, D A Fox.   

Abstract

While T cells have been implicated in the pathogenesis of inflammatory arthritis for more than three decades, the focus on the T helper type 17 (Th17) subset of CD4 T cells and their secreted cytokines, such as interleukin (IL)-17, is much more recent. Proinflammatory actions of IL-17 were first identified in the 1990s, but the delineation of a distinct Th17 subset in late 2005 has sparked great interest in the role of these cells in a broad range of immune-mediated diseases. This review summarizes current understanding of the role of Th17 cells and their products in both animal models of inflammatory arthritis and human immune-driven arthritides.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19758374      PMCID: PMC2819489          DOI: 10.1111/j.1365-2249.2009.04016.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  143 in total

1.  Essential role of IL-21 in B cell activation, expansion, and plasma cell generation during CD4+ T cell-B cell collaboration.

Authors:  Stefan Kuchen; Rachel Robbins; Gary P Sims; Chen Sheng; Terence M Phillips; Peter E Lipsky; Rachel Ettinger
Journal:  J Immunol       Date:  2007-11-01       Impact factor: 5.422

2.  Evidence that rheumatoid arthritis synovial T cells are similar to cytokine-activated T cells: involvement of phosphatidylinositol 3-kinase and nuclear factor kappaB pathways in tumor necrosis factor alpha production in rheumatoid arthritis.

Authors:  Fionula M Brennan; Amanda L Hayes; Cathleen J Ciesielski; Patricia Green; Brian M J Foxwell; Marc Feldmann
Journal:  Arthritis Rheum       Date:  2002-01

3.  Interleukin-17 acts independently of TNF-alpha under arthritic conditions.

Authors:  Marije I Koenders; Erik Lubberts; Fons A J van de Loo; Birgitte Oppers-Walgreen; Liduine van den Bersselaar; Monique M Helsen; Jay K Kolls; Franco E Di Padova; Leo A B Joosten; Wim B van den Berg
Journal:  J Immunol       Date:  2006-05-15       Impact factor: 5.422

4.  The clinical role of IL-23p19 in patients with rheumatoid arthritis.

Authors:  H-R Kim; H-S Kim; M-K Park; M-L Cho; S-H Lee; H-Y Kim
Journal:  Scand J Rheumatol       Date:  2007 Jul-Aug       Impact factor: 3.641

5.  Induction of cartilage damage by overexpression of T cell interleukin-17A in experimental arthritis in mice deficient in interleukin-1.

Authors:  Marije I Koenders; Erik Lubberts; Birgitte Oppers-Walgreen; Liduine van den Bersselaar; Monique M Helsen; Jay K Kolls; Leo A B Joosten; Wim B van den Berg
Journal:  Arthritis Rheum       Date:  2005-03

6.  Transforming growth factor-beta production by synovial tissues from rheumatoid patients and streptococcal cell wall arthritic rats. Studies on secretion by synovial fibroblast-like cells and immunohistologic localization.

Authors:  R Lafyatis; N L Thompson; E F Remmers; K C Flanders; N S Roche; S J Kim; J P Case; M B Sporn; A B Roberts; R L Wilder
Journal:  J Immunol       Date:  1989-08-15       Impact factor: 5.422

7.  Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells.

Authors:  Eva V Acosta-Rodriguez; Laura Rivino; Jens Geginat; David Jarrossay; Marco Gattorno; Antonio Lanzavecchia; Federica Sallusto; Giorgio Napolitani
Journal:  Nat Immunol       Date:  2007-05-07       Impact factor: 25.606

Review 8.  Cells of the synovium in rheumatoid arthritis. T lymphocytes.

Authors:  Steven K Lundy; Sujata Sarkar; Laura A Tesmer; David A Fox
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

9.  Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy.

Authors:  Norihiro Nishimoto; Nobuyuki Miyasaka; Kazuhiko Yamamoto; Shinichi Kawai; Tsutomu Takeuchi; Junichi Azuma; Tadamitsu Kishimoto
Journal:  Mod Rheumatol       Date:  2008-11-01       Impact factor: 3.023

10.  Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation.

Authors:  Craig A Murphy; Claire L Langrish; Yi Chen; Wendy Blumenschein; Terrill McClanahan; Robert A Kastelein; Jonathon D Sedgwick; Daniel J Cua
Journal:  J Exp Med       Date:  2003-12-08       Impact factor: 14.307

View more
  31 in total

1.  Involvement of T helper type 17 and regulatory T cell activity in tumour immunology of bladder carcinoma.

Authors:  L J Chi; H T Lu; G L Li; X M Wang; Y Su; W H Xu; B Z Shen
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

2.  Corrigendum.

Authors: 
Journal:  Clin Exp Immunol       Date:  2018-08       Impact factor: 4.330

3.  Broadening the translational immunology landscape.

Authors:  M Peakman
Journal:  Clin Exp Immunol       Date:  2012-12       Impact factor: 4.330

Review 4.  Rheumatoid arthritis vaccine therapies: perspectives and lessons from therapeutic ligand epitope antigen presentation system vaccines for models of rheumatoid arthritis.

Authors:  Kenneth S Rosenthal; Katalin Mikecz; Harold L Steiner; Tibor T Glant; Alison Finnegan; Roy E Carambula; Daniel H Zimmerman
Journal:  Expert Rev Vaccines       Date:  2015-03-18       Impact factor: 5.217

5.  Tinospora cordifolia inhibits autoimmune arthritis by regulating key immune mediators of inflammation and bone damage.

Authors:  K M Sannegowda; S H Venkatesha; K D Moudgil
Journal:  Int J Immunopathol Pharmacol       Date:  2015-10-14       Impact factor: 3.219

Review 6.  T helper cell subsets in arthritis and the benefits of immunomodulation by 1,25(OH)₂ vitamin D.

Authors:  Amolak S Bansal; Frances Henriquez; Nazira Sumar; Sanjeev Patel
Journal:  Rheumatol Int       Date:  2011-09-15       Impact factor: 2.631

7.  Estrogen, SNP-Dependent Chemokine Expression and Selective Estrogen Receptor Modulator Regulation.

Authors:  Ming-Fen Ho; Tim Bongartz; Mohan Liu; Krishna R Kalari; Paul E Goss; Lois E Shepherd; Matthew P Goetz; Michiaki Kubo; James N Ingle; Liewei Wang; Richard M Weinshilboum
Journal:  Mol Endocrinol       Date:  2016-02-11

8.  Carbon monoxide inhibits T cell activation in target organs during systemic lupus erythematosus.

Authors:  J P Mackern-Oberti; J Obreque; G P Méndez; C Llanos; A M Kalergis
Journal:  Clin Exp Immunol       Date:  2015-07-07       Impact factor: 4.330

9.  Novel therapeutic compound tuftsin-phosphorylcholine attenuates collagen-induced arthritis.

Authors:  T Bashi; O Shovman; M Fridkin; A Volkov; I Barshack; M Blank; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  2016-02-04       Impact factor: 4.330

10.  Toll/Interleukin-1 Receptor Domain Derived from TcpC (TIR-TcpC) Ameliorates Experimental Autoimmune Arthritis by Down-modulating Th17 Cell Response.

Authors:  Shweta Pasi; Ravi Kant; Avadhesha Surolia
Journal:  J Biol Chem       Date:  2016-03-28       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.